Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data

Affiliations

• ¹ Service and Central Laboratory of Hematology, Service of Immuno-oncology, Departments of Oncology and Laboratory Medicine and Pathology, University Hospital Lausanne, Lausanne, Switzerland.
• ² Division of Hematology/ Oncology, Clinic Hirslanden, Zurich, Switzerland.
• ³ Division of Hematology, Division of Pediatric Oncology and Hematology, University Hospital Geneva, Geneva, Switzerland.
• ⁴ Department of Medical Oncology, Department of Hematology and Central Hematology Laboratory, University Hospital Bern, Bern, Switzerland.
• ⁵ Division of Hematology/ Oncology, Cantonal Hospital, St. Gallen, Switzerland.
• ⁶ Division of Hematology/ Oncology, Cantonal Hospital, Aarau, Switzerland.
• ⁷ Department of Immunology/ Hematology/ Oncology/ Stem Cell Transplantation and Gene Therapy, University Children's Hospital Zurich, Zurich, Switzerland.
• ⁸ Swiss Blood Stem Cells, Swiss Transfusion SRC, Bern, Switzerland.
• ⁹ Hematology Division, University Hospital Basel, Basel, Switzerland.
• ¹⁰ Hematology Division, Cantonal Hospital, Lucerne, Switzerland.
• ¹¹ Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
• ¹² Division of Hematology, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, EOC, Bellinzona, Switzerland.